ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 69 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $30,010,000 | -27.5% | 8,002,700 | 0.0% | 0.01% | -28.6% |
| Q3 2021 | $41,374,000 | +21.4% | 8,002,700 | 0.0% | 0.01% | +16.7% |
| Q2 2021 | $34,092,000 | -19.8% | 8,002,700 | 0.0% | 0.01% | -25.0% |
| Q1 2021 | $42,494,000 | -1.5% | 8,002,700 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $43,135,000 | -32.5% | 8,002,700 | 0.0% | 0.01% | -42.9% |
| Q3 2020 | $63,862,000 | -20.3% | 8,002,700 | 0.0% | 0.01% | -26.3% |
| Q2 2020 | $80,107,000 | +268.0% | 8,002,700 | 0.0% | 0.02% | +216.7% |
| Q1 2020 | $21,767,000 | +167.0% | 8,002,700 | +17.8% | 0.01% | +200.0% |
| Q4 2019 | $8,151,000 | -20.5% | 6,792,700 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $10,257,000 | -62.4% | 6,792,700 | 0.0% | 0.00% | -66.7% |
| Q2 2019 | $27,307,000 | -6.5% | 6,792,700 | 0.0% | 0.01% | -14.3% |
| Q1 2019 | $29,209,000 | -25.2% | 6,792,700 | 0.0% | 0.01% | -36.4% |
| Q4 2018 | $39,058,000 | -57.6% | 6,792,700 | 0.0% | 0.01% | -50.0% |
| Q3 2018 | $92,109,000 | +8.0% | 6,792,700 | -5.5% | 0.02% | +22.2% |
| Q2 2018 | $85,306,000 | +11.8% | 7,186,700 | +5.8% | 0.02% | +5.9% |
| Q1 2018 | $76,282,000 | +68.1% | 6,792,700 | 0.0% | 0.02% | +70.0% |
| Q4 2017 | $45,375,000 | -18.4% | 6,792,700 | 0.0% | 0.01% | -23.1% |
| Q3 2017 | $55,632,000 | +82.4% | 6,792,700 | 0.0% | 0.01% | +85.7% |
| Q2 2017 | $30,499,000 | -18.5% | 6,792,700 | 0.0% | 0.01% | -22.2% |
| Q1 2017 | $37,428,000 | +106.3% | 6,792,700 | +51.6% | 0.01% | +80.0% |
| Q4 2016 | $18,146,000 | -44.1% | 4,480,486 | -2.6% | 0.01% | -37.5% |
| Q3 2016 | $32,437,000 | -13.5% | 4,601,000 | 0.0% | 0.01% | -20.0% |
| Q2 2016 | $37,498,000 | +0.2% | 4,601,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $37,406,000 | -32.6% | 4,601,000 | 0.0% | 0.01% | -37.5% |
| Q4 2015 | $55,488,000 | +170.5% | 4,601,000 | +168.4% | 0.02% | +166.7% |
| Q3 2015 | $20,516,000 | +2.3% | 1,713,918 | +56.7% | 0.01% | +20.0% |
| Q2 2015 | $20,048,000 | – | 1,093,750 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 5,555,461 | $5,416,574 | 2.98% |
| NEA Management Company, LLC | 17,079,778 | $16,651,076 | 1.25% |
| EcoR1 Capital, LLC | 27,404,070 | $26,716,228 | 0.82% |
| MPM BioImpact LLC | 5,095,912 | $4,968,514 | 0.77% |
| PFM Health Sciences, LP | 10,520,231 | $10,256,173 | 0.51% |
| Long Focus Capital Management, LLC | 12,346,417 | $12,036,522 | 0.46% |
| Matrix Capital Management Company, LP | 38,974,185 | $37,995,933 | 0.29% |
| Acuitas Investments, LLC | 541,201 | $527,617 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 1,743,619 | $1,699,854 | 0.17% |
| Key Client Fiduciary Advisors, LLC | 263,989 | $257,363 | 0.13% |